LeMaitre Vascular AI Price Prediction

With EPS of 2.32 and a PE ratio of 36.78, LeMaitre Vascular is priced as a quality, growth-oriented medtech name, but not cheaply. The valuation implies investors expect continued earnings expansion, yet the information provided does not indicate an obvious near-term acceleration or deterioration in fundamentals. Overall, the setup looks balanced: solid profitability but a valuation that already embeds optimistic expectations.

• EPS of 2.32 combined with a PE of 36.78 suggests the market is paying a growth multiple rather than a value multiple, typical for niche medical device companies with stable demand.
• The relatively high PE indicates expectations for continued earnings growth; if growth slows, the stock could be vulnerable to multiple compression.
• No direct revenue, margin, or net income trend data is provided here, so the current valuation must be interpreted as the market’s forward-looking confidence rather than a clear reflection of recent financial acceleration.

The stock trades at $85.33, slightly below its 200-day moving average of $86.35, and is up 2.8% over the last month, indicating a modest positive drift but not a strong uptrend. An RSI of 44.98 is in the middle of the range, suggesting neither overbought nor oversold conditions. Overall, technicals point to a consolidating stock with no strong directional signal.

• Price modestly below the 200-day moving average ($85.33 vs. $86.35) suggests the long-term trend is flat to slightly negative, but the gap is small and not strongly bearish.
• A 2.8% gain over the last month signals mild positive momentum, but not the kind of strength typically associated with a clear bullish breakout.
• RSI at 44.98 is neutral, indicating balanced buying and selling pressure and no imminent technical exhaustion on either side.

LeMaitre Vascular’s stock currently reflects a reasonably profitable, niche medtech company valued at a growth multiple, but without strong confirming signals from technicals or alternative data. The price action and RSI are neutral, while hiring and digital engagement trends are soft, tempering the otherwise solid earnings profile implied by the PE and EPS. Overall, the balance of signals points to a neutral outlook, with upside dependent on the company delivering continued growth to justify its valuation.

• Valuation and earnings suggest a quality business, but the premium multiple already prices in meaningful growth, limiting margin of safety.
• Technical and alternative data indicators do not currently show strong positive momentum, leading to a cautiously neutral stance rather than clearly bullish or bearish.